BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 15967331)

  • 21. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease.
    Romberg-Camps MJ; Dagnelie PC; Kester AD; Hesselink-van de Kruijs MA; Cilissen M; Engels LG; Van Deursen C; Hameeteman WH; Wolters FL; Russel MG; Stockbrügger RW
    Am J Gastroenterol; 2009 Feb; 104(2):371-83. PubMed ID: 19174787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crohn's colitis: the incidence of dysplasia and adenocarcinoma in surgical patients.
    Maykel JA; Hagerman G; Mellgren AF; Li SY; Alavi K; Baxter NN; Madoff RD
    Dis Colon Rectum; 2006 Jul; 49(7):950-7. PubMed ID: 16729218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of esophagogastroduodenoscopy in the initial assessment of children with inflammatory bowel disease.
    Lemberg DA; Clarkson CM; Bohane TD; Day AS
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1696-700. PubMed ID: 16246188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased risk for demyelinating diseases in patients with inflammatory bowel disease.
    Gupta G; Gelfand JM; Lewis JD
    Gastroenterology; 2005 Sep; 129(3):819-26. PubMed ID: 16143121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perianal disease predicts changes in Crohn's disease phenotype-results of a population-based study of inflammatory bowel disease phenotype.
    Tarrant KM; Barclay ML; Frampton CM; Gearry RB
    Am J Gastroenterol; 2008 Dec; 103(12):3082-93. PubMed ID: 19086959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis--how much is irritable bowel syndrome?
    Burgmann T; Clara I; Graff L; Walker J; Lix L; Rawsthorne P; McPhail C; Rogala L; Miller N; Bernstein CN
    Clin Gastroenterol Hepatol; 2006 May; 4(5):614-20. PubMed ID: 16630762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study.
    Ott C; Obermeier F; Thieler S; Kemptner D; Bauer A; Schölmerich J; Rogler G; Timmer A
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):917-23. PubMed ID: 18794607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colorectal neoplasia in Crohn's colitis: a retrospective comparative study with ulcerative colitis.
    Svrcek M; Cosnes J; Beaugerie L; Parc R; Bennis M; Tiret E; Fléjou JF
    Histopathology; 2007 Apr; 50(5):574-83. PubMed ID: 17394493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for inflammatory bowel disease in the general population.
    García Rodríguez LA; González-Pérez A; Johansson S; Wallander MA
    Aliment Pharmacol Ther; 2005 Aug; 22(4):309-15. PubMed ID: 16097997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carcinogenesis in inflammatory bowel disease.
    Herszenyi L; Miheller P; Tulassay Z
    Dig Dis; 2007; 25(3):267-9. PubMed ID: 17827953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early onset of ulcerative colitis: long-term follow-up with special reference to colorectal cancer and primary sclerosing cholangitis.
    Lindberg J; Stenling R; Palmqvist R; Rutegård J
    J Pediatr Gastroenterol Nutr; 2008 May; 46(5):534-8. PubMed ID: 18493208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of corticosteroid-dependent and corticosteroid-refractory inflammatory bowel disease: analysis of a Chinese cohort study.
    Chow DK; Sung JJ; Tsoi KK; Wong VW; Wu JC; Leong RW; Chan FK
    Aliment Pharmacol Ther; 2009 Apr; 29(8):843-54. PubMed ID: 19154567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study.
    Loras C; Saro C; Gonzalez-Huix F; Mínguez M; Merino O; Gisbert JP; Barrio J; Bernal A; Gutiérrez A; Piqueras M; Calvet X; Andreu M; Abad A; Ginard D; Bujanda L; Panés J; Torres M; Fernández-Bañares F; Viver JM; Esteve M;
    Am J Gastroenterol; 2009 Jan; 104(1):57-63. PubMed ID: 19098850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A common genetic background for inflammatory bowel disease and ankylosing spondylitis: a genealogic study in Iceland.
    Thjodleifsson B; Geirsson AJ; Björnsson S; Bjarnason I
    Arthritis Rheum; 2007 Aug; 56(8):2633-9. PubMed ID: 17665420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammatory bowel disease associated with Yersinia enterocolitica O:3 infection.
    Saebo A; Vik E; Lange OJ; Matuszkiewicz L
    Eur J Intern Med; 2005 Jun; 16(3):176-182. PubMed ID: 15967332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of Dysplasia or Cancer in 3.5% of Patients With Inflammatory Bowel Disease and Colonic Strictures.
    Fumery M; Pineton de Chambrun G; Stefanescu C; Buisson A; Bressenot A; Beaugerie L; Amiot A; Altwegg R; Savoye G; Abitbol V; Bouguen G; Simon M; Duffas JP; Hébuterne X; Nancey S; Roblin X; Leteurtre E; Bommelaer G; Lefevre JH; Brunetti F; Guillon F; Bouhnik Y; Peyrin-Biroulet L
    Clin Gastroenterol Hepatol; 2015 Oct; 13(10):1770-5. PubMed ID: 26001338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammatory bowel diseases as an intermediate stage between normal and cancer: a FTIR-microspectroscopy approach.
    Argov S; Sahu RK; Bernshtain E; Salman A; Shohat G; Zelig U; Mordechai S
    Biopolymers; 2004 Dec; 75(5):384-92. PubMed ID: 15457432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The variable risk of colorectal cancer in patients with inflammatory bowel disease.
    Lindgren S
    Eur J Intern Med; 2005 Jun; 16(3):139-140. PubMed ID: 15967326
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.